A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 16, Issue 3, 2006, Pages 336-350

  Pavuluri, Mani N ^a   Henry, David B ^a   Carbray, Julie A ^a   Sampson, Gwen A ^a   Naylor, Michael W ^a   Janicak, Philip G ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; CLONIDINE; LITHIUM; RISPERIDONE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CHILD ABUSE; CHILD DEPRESSION RATING SCALE REVISED; CHILD HOSPITALIZATION; CHILD SEXUAL ABUSE; CHILDREN GLOBAL ASSESSMENT SCALE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ENURESIS; FAMILY HISTORY; FATIGUE; FEMALE; FLU LIKE SYNDROME; HUMAN; HYPERPROLACTINEMIA; INCREASED APPETITE; MALE; MANIA; MONOTHERAPY; MUSCLE STIFFNESS; NAUSEA; ONSET AGE; OPEN STUDY; POLYURIA; PRESCHOOL CHILD; PSYCHOPHARMACOTHERAPY; RATING SCALE; RELAPSE; RESTLESSNESS; SCHOOL CHILD; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; STOMACH PAIN; TREATMENT OUTCOME; TREMOR; VOMITING; WEIGHT GAIN; YOUNG MANIA RATING SCALE;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM; MALE; RISPERIDONE; TREATMENT OUTCOME;

EID: 33745179866     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2006.16.336     Document Type: Article

References (68)

1. Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL, Risperidone Disruptive Behavior Study Group: Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 159:1337-1346, 2002.
2. American Psychiatric Association: Diagnostic And Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington (DC), American Psychiatric Association, 1994.
3. Armenteros JL, Whitaker AH, Welikson M, Stedge DJ, Gorman J: Risperidone in adolescents with schizophrenia: An open-pilot study. J Am Acad Child Adolesc Psychiatry 36:694-700, 1997.
4. Bassarath L: Medication strategies in childhood aggression: A review. Can J Psychiatry 48:367-373, 2003.
5. Biederman J, Mick E, Prince J, Bostic JO, Wilens TE, Spencer T: Systematic chart review of the pharmacological treatment of comorbid attention-deficit/hyperactivity disorder in youth with bipolar disorder. J Child Adolesc Psychopharmacol 156:1931-1937, 1999.
6. Biederman J, Mick E, Spencer T, Wilens TE, Faraone SV: Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol 10:185-192, 2000.
7. Biederman J, Mick E, Wozniak J, et al.: An open-label trial of risperidone in children with bipolar disorder and comorbid attention-deficit/ hyperactivity disorder. J Child Adolesc Psychopharmacol in press.
8. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsavr SC, Davis JM, Rush AJ, Small JG: Efficacy of divalproex versus lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 271:918-924, 1994.
9. Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vagrero M, Svensson K: A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 66:111-121, 2005.
10. Buitelaar JK, van der Gaag RJ, Cohen-Kettenis P, Melman CT: A randomized, controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry 62:239-248, 2001.
11. Carlson GA: The bottom line. J Child Adolesc Psychopharmacol, 13:115-118, 2003.
12. Carlson GA, Bromet EJ, Driessens C, Mojtabai R, Schwartz JE: Age at onset, childhood psychopathology, and 2-year outcome in psychotic bipolar disorder. Am J Psychiatry 159:307-309, 2002.
13. Centers for Disease Control and Prevention: Clinical Growth Charts from the National Health and Nutrition Examination Survey. Atlanta (Georgia), National Center for Health Statistics, 2003. Online document at: www.cdc.gov/nchs/about/major/nhanes/growthcharts/clinical_charts.htm.
14. Cesena M, Gonzalez-Heydrich J, Szigethy E, Kohlenberg T, DeMaso D: A case series of eight aggressive young children treated with risperidone. J Child Adolesc Psychopharmacol 12:337-345, 2002.
15. Chang KD, Blasey CM, Ketter TA, Steiner H: Temperament characteristics of child and adolescent bipolar offspring. J Affect Disord 77:11-19, 2003.
16. DelBello M, Schwiers M, Rosenberg L, Strakowski S: A double-blind, randomized, placebo-controlled study of quetipine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 41:1216-1223, 2002.
17. Delong GR, Nieman MA: Lithium-induced behavior changes in children with symptoms suggesting manic-depressive illness. Psychopharmacol Bull 19:258-265, 1983.
18. DelBello MP, Soutullo CA, Hendricks W, Niemeier RT, McElroy SL, Strakowski SM: Prior stimulant treatment in adolescents with bipolar disorder: Association with age at onset. Bipolar Disord 3:53-57, 2001.
19. Emslie GJ, Hughes CW, Crismon ML, Lopez M, Pliska S, Toprac MG, Boemer C, Texas Children's Medication Mental Algorithm Project (CMAP): A feasibility study of the childhood depression medication algorithm: The Texas Children's Medication Mental Algorithm Project (CMAP). J Am Acad Child Adolesc Psychiatry 43:519-527, 2004.
20. Findling RL, Kusumakar V, Daneman D, Moshang T, De Smedt G, Binder C: Prolactin levels during long-term risperidone treatment in children and adolescents. J Clin Psychiatry 64:1362-1369, 2003b.
21. Findling RL, McNamara N, Branicky L, Schluchter M, Lemon E, Blumer J: A double-blind pilot study of risperidone in the treatment of conduct disorder. J Am Acad Child Adolesc Psychiatry 39:509-516, 2000.
22. Findling RL, McNamara NK, Gracious BL, Youngstrom EA, Stansbrey RJ, Reed MD: Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 42:895-901, 2003a.
23. Findling RL, McNamara NK, Youngstrom EA, Stansbrey R, Gracious BL, Reed MD, Calabrese JR: Double-blind, 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:409-417, 2005.
24. Fisher L, Dixon D, Herson J, Frankowski R, Hearon M, Pearce K: Intention to treat in clinical trials. In: Statistical Issues in Drug Research and Development. Edited by Pearce K. New York, Marcel Dekker, 1990, pp 331-350.
25. Gaffney GR, Perry PJ, Lund BC, Bever-Stille KA, Arndt S, Kuperman S: Risperidone versus clonidine in the treatment of children and adolescents with Tourette syndrome. J Am Acad Child Adolesc Psychiatry 41:330-336, 2002.
26. Geller B, Cooper TB, Sun K, Zimerman MA, Frazier J, Williams M, Heath J: Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 37:171-178, 1998a.
27. Geller B, Warner K, Williams M, Zimerman B: Prepubertal and young adolescent bipolarity versus ADHD: Assessment and validity using the WASH-U-KSADS, CBCL, and TRF. J Affect Disord 51:93-100, 1998b.
28. Geller B, Zimerman B, Williams M, DelBello MP, Frazier J, Beringer L: Phenomenology of prepubertal and early adolescent bipolar disorder: Examples of elated mood, grandiose behaviors, decreased need for sleep, racing thoughts, and hypersexuality. J Child Adolesc Psychopharmacol 12:3-9, 2002a.
29. Geller B, Zimerman B, Williams M, DelBello M, Bolhofner K, Craney J, Frazier J, Beringer L, Nickelsburg M: DSM-IV mania symptoms in a prepubertal and early adolescent BD phenotype compared to attention-deficit/hyperactive and normal controls. J Child Adolesc Psychopharmacol 12:11-25, 2002b.
30. Gram LF, Rafaelsen OJ: Lithium treatment of psychotic children and adolescents: A controlled, clinical trial. Acta Psychiatrica Scandinavica 48:253-260, 1972.
31. Guy W: ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville (Maryland), U.S. Department of Health, Education, and Welfare, 1976.
32. Hyun M, Friedman SD, Dunner DL: Relationship of childhood physical and sexual abuse to adult bipolar disorder. Bipolar Disord 2:131-135, 2000.
33. Kafantaris V, Coletti D, Dicker R, Padula G, Kane J: Adjunctive antipsychotic treatment of adolescents with bipolar psychosis. J Am Acad Child Adolesc Psychiatry 40:1448-1456, 2001b.
34. Kafantaris V, Coletti D, Dicker R, Padula G, Kane J: Lithium treatment of acute mania in adolescents: A large, open trial. J Am Acad Child Adolesc Psychiatry 42:1038-1045, 2003.
35. Kafantaris V, Coletti DJ, Dicker R, Padula G, Kane JM, Pleak RR, Alvir JMJ: Lithium treatment of acute mania in adolescents: A placebo-controlled discontinuation study. J Am Acad Child Adolesc Psychiatry 43:984-993, 2004.
36. Kafantaris V, Dicker R, Coletti D, Kane J: Adjunctive antipsychotic treatment is necessary for adolescents with psychotic mania. J Child Adolesc Psychopharmacol 11:409-413, 2001a.
37. Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M: Treatment guidelines for children and adolescents with bipolar disorder: Child psychiatric workgroup on bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:213-235, 2005.
38. Kowatch R, Suppes T, Carmody T, Bucci J, Hume J, Kromelis M, Emslie G, Weinberg W, Rush A: Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescent with BD. J Am Acad Child Adolesc Psychiatry 39:713-720, 2000.
39. Kowatch R, Sethuraman G, Hume J, Kromelis M, Weinberg W: Combination pharmacotherapy in children and adolescents with BD. Biol Psychiatry 53:978-984, 2003.
40. Lena B: Lithium in child and adolescent psychiatry. Arch Gen Psychiatry 36:854-855, 1979.
41. Leverich GS, McElroy SL, Suppes T, Keck PE, Jr, Denicoff KD, Nolen WA, Alshuler, Rush AJ, Kupka R, Frye MA, Autio KA, Post RM: Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry 51:288-297, 2002.
42. McClellan J, Werry J: Evidence-based treatments in child and adolescent psychiatry: An inventory. J Am Acad Child Adolesc Psychiatry 42:1388-1400, 2003.
43. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D: Research units on pediatric psychopharmacology autism network: Risperidone in children with autism and serious behavioral problems. N Engl J Med 347:314-321, 2002.
44. McKnew DH, Cytryn L, Buchsbaum MS, Hamovit J, Lamour M, Rapoport JL, Gershon ES: Lithium in children of lithium-responding parents. Psychiatry Res 4:171-180, 1981.
45. Mota-Castillo M, Torruella A, Engels B, Perez J, Dedrick C, Gluckman M: Valproate in very young children: An open case series with a brief follow-up. J Affect Disord 67:193-197, 2001.
46. Pavuluri MN, Henry DW, Devineni B, Carbray JA, Naylor MW, Janicak PG: A pharmacotherapy algorithm for stabilization and maintenance for pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 43:859-867, 2004a.
47. Pavuluri MN, Henry DW, Naylor M, Carbray J, Janicak PG: Divalproex sodium in pediatric mixed mania: A six-month, open-label trial. Bipolar Disord 7:266-273, 2005.
48. Pavuluri MN, Henry DW, Naylor M, Sampson G, Carbray J, Janicak PG: A prospective trial of combination therapy of risperidone with lithium or divalproex sodium in pediatric mania. J Affect Disord 82(Suppl 1):103-111, 2004b.
49. Pavuluri MN, Janicak PG: Handbook of Pharmacotherapy: A Life Span Approach. Baltimore (Maryland)/Philadelphia, (Pennsylvania), Lippincott Williams & Wilkins, 2004.
50. Pavuluri MN, Janicak P, Carbray JA: Topiramate plus risperidone for controlling weight gain and symptoms in preschool mania. J Child Adolesc Psychopharmacol 12:271-273, 2002a.
51. Pavuluri MN, Naylor MW, Janicak PG: Recognition and treatment of pediatric bipolar disorder. Contemp Psychiatry 1:1-9, 2002b.
52. Pliszka SR, Lopez M, Crismon ML, Toprac MG, Hughes CW, Emslie GJ, Boemer C: A feasibility study of the children's medication algorithm project (CMAP) algorithm for the treatment of ADHD. J Am Acad Child Adolesc Psychiatry 42:279-287, 2003.
53. Poznanski E, Grossman J, Buchsbaum Y, Banegas M, Freeman L, Gibbons R: Preliminary studies of the reliability and validity of the children's depression rating scale. J Am Acad Child Psychiatry 23:191-197, 1984a.
54. Poznanski E, Israel M, Grossman J: Hypomania in a four year old. J Am Acad Child Psychiatry 23:105-110, 1984b.
55. Scheffer R, Kowatch R, Carmody T, Rush J: Randomized, placebo-controlled trial of dexedrine for symptoms of comorbid ADHD in pediatric bipolar disorder. Am J Psychiatry 162:58-64, 2005.
56. Segal J, Berk M, Brook S: Risperidone compared with both lithium and haloperidol in mania: A double-blind, randomized, controlled trial. Clin Neuropharmacol 21:176-180, 1998.
57. Shaffer D, Gould M, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S: Children's global assessment scale (C-GAS). Arch Gen Psychiatry 40:1228-1231, 1983.
58. Small JG, Klapper MH, Milstein V, Kellams JJ, Miller MJ, Marhenke JD, Smal IF: Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry 48:915-921, 1991.
59. Snyder R, Turgay A, Aman M, Binder C, Fisman S, Carroll A: Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad Child Adolesc Psychiatry 41:1026-1036, 2002.
60. Soutullo CA, DelBello MP, Ochsner JE, McElroy SL, Taylor SA, Strakowski SM, Keck PE, Jr: Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment. J Affect Disord 70:323-327, 2002.
61. Spearing M, Post R, Leverich G, Brandt D, Nolen W: Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): The CGI-BP. Psychiatry Res 73:159-171, 1997.
62. Strober M, De Antonio M, Schmidt-Lackner S, Freeman R, Lampert C, Diamond J: Early childhood attention-deficit/hyperactivity disorder predicts poorer response to acute lithium therapy in adolescent mania. J Affect Disord 51:145-151, 1998.
63. Strober M, Morrell W, Burroughs J, Lampert C, Danforth H, Freeman R: A family study of bipolar I disorder in adolescence: Early onset of symptoms linked to increased family loading and lithium resistance. J Affect Disord 15:255-268, 1988.
64. Task Force on Research Diagnostic Criteria: Infancy and Preschool: Research diagnostic criteria for infants and preschool children: The process and empirical support. J Am Acad Child Adolesc Psychiatry 42:1504-1512, 2003.
65. Tuzun U, Zoroglu S, Savas H: A 5-year-old boy with recurrent mania successfully treated with carbamazepine. Psychiatry Clin Neurosci 56:589-591, 2002.
66. Weissman M, Wickramaratne P, Adams P, Wolk S, Verdeli H, Olfson M: Brief screening for the family history: The Family History Screen. Arch Gen Psychiatry 57:675-682, 2000.
67. Wilens T, Biederman J, Brown S, Monuteaux M, Prince J, Spencer T: Patterns of psychopathology and dysfunction in clinically referred preschoolers. J Dev Behav Pediatr 23(Suppl 1):S31-S36, 2002.
68. Young R, Biggs J, Ziegler V, Meyer D: A rating scale for mania: Reliability, validity, and sensitivity. Br J Psychiatry 133:429-435, 1978.